{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:24:29Z","timestamp":1775132669263,"version":"3.50.1"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In this cross-sectional study, we aimed to evaluate the factors associated with psoriasis symptom worsening and impaired quality of life (QoL) in individuals with psoriasis during the COVID-19 pandemic lockdown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>During the second COVID-19 national lockdown (January\u2013April 2021) in Lithuania, individuals diagnosed with psoriasis were invited to fill in an anonymous online survey including sociodemographic and life-style factors, psoriasis-related clinical symptoms, the Dermatology Life Quality Index (DLQI) and the Patients' Health Questionnaire (PHQ).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 297 respondents completed the survey. The majority of them (52.5%) reported worsened clinical symptoms of psoriasis during the COVID-19 lockdown period. In total, 43.1% of responders reported significant depressive symptoms (PHQ-9 \u2265 10) and 23.6% reported impaired disease-related QoL (DLQI &amp;gt; 10). The strongest predictor of psoriasis symptoms worsening was the need for changes in psoriasis treatment, with an odds ratio (OR) of 2.73 (95% CI 1.37\u20135.44, <jats:italic>p<\/jats:italic> = 0.004) and decreased income (OR = 2.33, 95% CI 1.30\u20134.17, <jats:italic>p<\/jats:italic> = 0.004). The strongest predictor of impaired QoL was male sex (OR = 3.35, 95% CI 1.70\u20136.59, p &amp;lt; 0.001). Contribution of specific depressive symptoms was evident for both models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Worsening of psoriasis symptoms during the COVID-19 lockdown was associated with decreased income, psoriasis treatment changes and depression symptoms. Impaired QoL was associated with male sex, symptom worsening and depression. Specific depression symptoms may have contributed to more symptom worsening and impaired QoL than the depressive symptomatology as a whole.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1027853","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:13:23Z","timestamp":1673381603000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors associated with worsened clinical symptoms of psoriasis and disease-related quality of life during the COVID-19 lockdown: A cross-sectional study"],"prefix":"10.3389","volume":"9","author":[{"given":"Julius","family":"Burkauskas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Slabadiene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelija","family":"Podlipskyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesta","family":"Steibliene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","article-title":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence","volume":"395","author":"Brooks","year":"2020","journal-title":"Lancet (London, England)."},{"key":"B2","first-page":"93","article-title":"Psychological distress and coronavirus fears during the initial phase of the COVID-19 pandemic in the United States","volume":"23","author":"French","year":"2020","journal-title":"J Ment Health Policy Econ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11886-021-01566-4","article-title":"COVID-19 and cardiovascular disease: a global perspective","volume":"23","author":"Pina","year":"2021","journal-title":"Curr Cardiol Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","article-title":"Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study","volume":"21","author":"Al-Hashel","year":"2020","journal-title":"J Headache Pain."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2021-4-4","article-title":"Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic","volume":"10","author":"Torres","year":"2021","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"110910","DOI":"10.1016\/j.jpsychores.2022.110910","article-title":"Relationship between sleep duration and quality and mental health before and during COVID-19 pandemic: Results of population-based studies in Brazil","volume":"158","author":"Sch\u00e4fer","year":"2022","journal-title":"J Psychosom Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e22288","DOI":"10.2196\/22288","article-title":"Association of socioeconomic changes due to the COVID-19 pandemic with health outcomes in patients with skin diseases: cross-sectional survey study","volume":"22","author":"Guo","year":"2020","journal-title":"J Med Internet Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet."},{"key":"B9","first-page":"278","article-title":"Diagnosis and management of psoriasis","volume":"63","author":"Kim","year":"2017","journal-title":"Can Fam Physician."},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"JEADV."},{"key":"B11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2340\/00015555-0838","article-title":"A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients","volume":"90","author":"Kotrulja","year":"2010","journal-title":"Acta Derm Venereol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12529-017-9637-4","article-title":"Subjective health complaints in individuals with psoriasis and psoriatic arthritis: associations with the severity of the skin condition and illness perceptions\u2013a cross-sectional study","volume":"24","author":"Nordb\u00f8","year":"2017","journal-title":"Int J Behav Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.22365\/jpsych.2017.281.54","article-title":"Psychological parameters of psoriasis","volume":"28","author":"Kouris","year":"2017","journal-title":"Psychiatrike."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5694\/mja2.50591","article-title":"Beyond skin deep: addressing comorbidities in psoriasis","volume":"212","author":"Kovitwanichkanont","year":"2020","journal-title":"Med J Aust."},{"key":"B19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12529-016-9617-0","article-title":"Emotion regulation in patients with psoriasis: correlates of disability, clinical dimensions, psychopathology symptoms","volume":"24","author":"Almeida","year":"2017","journal-title":"Int J Behav Med."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-022-10104-7.","article-title":"Quality of life among family of patients with atopic dermatitis and psoriasis","author":"Snyder","year":"2022","journal-title":"Int J Behav Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1087-0024.2003.09110.x","article-title":"Bos JD. Quality of life in patients with psoriasis: a systematic literature review","volume":"9","author":"Sprangers","year":"2004","journal-title":"J Investig Dermatol Symp Proc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5114\/pdia.2014.40927","article-title":"Itch, disease coping strategies and quality of life in psoriasis patients","volume":"31","author":"Ograczyk","year":"2014","journal-title":"Postepy dermatologii i alergologii."},{"key":"B23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.5114\/ada.2018.75810","article-title":"Dermatology Life Quality Index and disease coping strategies in psoriasis patients","volume":"36","author":"Liluashvili","year":"2019","journal-title":"Postepy dermatologii i alergologii."},{"key":"B24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4103\/ijdvl.IJDVL_114_19","article-title":"Type D personality is associated with poor quality of life, social performance, and psychological impairment in patients with moderate to severe psoriasis: a cross-sectional study of 130 patients","volume":"86","author":"Aguayo-Carreras","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"110552","DOI":"10.1016\/j.jpsychores.2021.110552","article-title":"Impact of COVID-19 on mental health according to prior depression status: a mental health survey of community prospective cohort data","volume":"148","author":"Jung","year":"2021","journal-title":"J Psychosom Res."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X20964347","article-title":"Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors","author":"Ibrahim","year":"2020","journal-title":"J Telemed Telecare."},{"key":"B27","doi-asserted-by":"publisher","first-page":"16020","DOI":"10.4088\/JCP.20com13363","article-title":"Psychiatry's niche role in the COVID-19 pandemic","volume":"81","author":"Goldberg","year":"2020","journal-title":"J Clini Psychiatry."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e010","DOI":"10.1097\/JW9.0000000000000010","article-title":"The impact of gender and sex in psoriasis: what to be aware of when treating women with psoriasis","volume":"8","author":"Guillet","year":"2022","journal-title":"Int J Women's Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s11136-016-1321-7","article-title":"Health-related quality of life in patients with psoriasis: a systematic review of the European literature","volume":"25","author":"Obradors","year":"2016","journal-title":"Qual Life Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.26444\/aaem\/112107","article-title":"Environmental risk factors and epigenetic alternations in psoriasis","volume":"27","author":"Roszkiewicz","year":"2020","journal-title":"AAEM."},{"key":"B31","first-page":"36","article-title":"Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation","volume":"9","author":"Ferreira","year":"2016","journal-title":"J Clin Aesthet Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.21101\/cejph.a5611","article-title":"Quality of life of patients with psoriasis","volume":"28","author":"\u0160mejkalov\u00e1","year":"2020","journal-title":"Cent Eur J Public Health."},{"key":"B33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0263027","DOI":"10.1371\/journal.pone.0263027","article-title":"Validation of the patient health questionnaire-9 and the generalized anxiety disorder-7 in Lithuanian student sample","volume":"17","author":"Pranckeviciene","year":"2022","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e14700","DOI":"10.1111\/dth.14700","article-title":"Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: a single-center experience","volume":"34","author":"Polat","year":"2021","journal-title":"Dermatologic Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2147\/PPA.S263843","article-title":"Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey","volume":"14","author":"Wang","year":"2020","journal-title":"Patient Prefer Adherence."},{"key":"B38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaad.2020.05.018","article-title":"Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: a web-based survey","volume":"83","author":"Kuang","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1111\/jdv.17450","article-title":"Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study","volume":"35","author":"Mahil","year":"2021","journal-title":"JEADV."},{"key":"B40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2340\/00015555-2218","article-title":"Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: a danish nationwide study","volume":"96","author":"Egeberg","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: a European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch Dermatol Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e22892","DOI":"10.7759\/cureus.22892","article-title":"Psoriasis in Saudi population: gender differences in clinical characteristics and quality of life","volume":"14","author":"Alamri","year":"2022","journal-title":"Cureus."},{"key":"B43","doi-asserted-by":"publisher","first-page":"105177","DOI":"10.1016\/j.jbspin.2021.105177","article-title":"Gender-related differences in disease activity and clinical features in patients with peripheral psoriatic arthritis: a multi-center study","volume":"88","author":"Duru\u00f6z","year":"2021","journal-title":"Joint Bone Spine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/bjd.20387","article-title":"Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study","volume":"185","author":"Maul","year":"2021","journal-title":"Br J Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e14849","DOI":"10.1111\/dth.14849","article-title":"Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech Republic","volume":"34","author":"Kojanova","year":"2021","journal-title":"Dermatol Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24365-5","article-title":"Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom","volume":"12","author":"Hampshire","year":"2021","journal-title":"Nat Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.15585\/mmwr.mm7013e2","article-title":"Symptoms of anxiety or depressive disorder and use of mental health care among adults during the COVID-19 pandemic\u2014United States, August 2020\u2013February 2021","volume":"70","author":"Vahratian","year":"2021","journal-title":"Morbid Mortal Wkly Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.eclinm.2021.101044","article-title":"Cognitive deficits in people who have recovered from COVID-19","volume":"39","author":"Hampshire","year":"2021","journal-title":"EClinicalMedicine."},{"key":"B49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpsychires.2022.01.029","article-title":"Individual obsessive-compulsive traits are associated with poorer adjustment to the easing of COVID-19 restrictions","volume":"148","author":"Fineberg","year":"2022","journal-title":"J Psychiatr Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5114\/pdia.2016.62286","article-title":"How does stigma affect people with psoriasis?","volume":"34","author":"\u0141akuta","year":"2017","journal-title":"Postepy Dermatol Alergo."},{"key":"B51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.clindermatol.2007.08.008","article-title":"Quality of life in patients with psoriasis and psoriasis arthritis with a special focus on stigmatization experience","volume":"25","author":"Schmid-Ott","year":"2007","journal-title":"Clin Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychores.2004.03.009","article-title":"Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20","volume":"58","author":"Richards","year":"2005","journal-title":"J Psychosom Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-014-0038-7","article-title":"Alexithymia, anxiety and depression in patients with psoriasis: a case\u2013control study","volume":"13","author":"Korkoliakou","year":"2014","journal-title":"Ann Gen Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1348\/014466502163949","article-title":"Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia","volume":"41","author":"Fortune","year":"2002","journal-title":"Br J Clin Psychol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1365-4632.2008.03726.x","article-title":"Alexithymia and dermatology: the state of the art","volume":"47","author":"Willemsen","year":"2008","journal-title":"Int J Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fpsyg.2020.00836","article-title":"Emotions, alexithymia, and emotion regulation in patients with psoriasis","volume":"11","author":"Panasiti","year":"2020","journal-title":"Front Psychol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"111017","DOI":"10.1016\/j.jpsychores.2022.111017","article-title":"The prevalence of alexithymia in psoriasis: A systematic review and meta-analysis","volume":"161","author":"Tang","year":"2022","journal-title":"J Psychosom Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1192\/bjpo.bp.115.001685","article-title":"Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies","volume":"2","author":"Mitchell","year":"2016","journal-title":"BJPsych open."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e25987","DOI":"10.7759\/cureus.25987","article-title":"Psoriasis flares in patients with COVID-19 infection or vaccination: a case series","volume":"14","author":"Shah","year":"2022","journal-title":"Cureus."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e14684","DOI":"10.1111\/dth.14684","article-title":"Psoriasis flare after influenza vaccination in Covid-19 era: A report of four cases from a single center","volume":"34","author":"Mungu\u00eda-Calzada","year":"2021","journal-title":"Dermatol Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40257-022-00721-z","article-title":"New onset and exacerbations of psoriasis following covid-19 vaccines: a systematic review","volume":"23","author":"Wu","year":"2022","journal-title":"Am J Clin Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e15900","DOI":"10.1111\/dth.15900","article-title":"Psoriasis exacerbation after COVID-19 vaccines: a brief report of the reported cases","author":"El-Qushayri","year":"2022","journal-title":"Dermatol Ther."},{"key":"B63","author":"Mathieu","year":"","journal-title":"Coronavirus Pandemic (COVID-19)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1027853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:13:32Z","timestamp":1673381612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1027853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":63,"alternative-id":["10.3389\/fmed.2022.1027853"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1027853","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1027853"}}